D Sreedhar

401 total citations
41 papers, 174 citations indexed

About

D Sreedhar is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Management of Technology and Innovation. According to data from OpenAlex, D Sreedhar has authored 41 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 13 papers in Economics and Econometrics and 6 papers in Management of Technology and Innovation. Recurrent topics in D Sreedhar's work include Pharmaceutical Economics and Policy (11 papers), Pharmaceutical Quality and Counterfeiting (8 papers) and Intellectual Property and Patents (6 papers). D Sreedhar is often cited by papers focused on Pharmaceutical Economics and Policy (11 papers), Pharmaceutical Quality and Counterfeiting (8 papers) and Intellectual Property and Patents (6 papers). D Sreedhar collaborates with scholars based in India and Czechia. D Sreedhar's co-authors include N Udupa, Virendra S Ligade, G. Subramanian, Manthan D Janodia, K. Ramesh, Smitha Prabhu, Susovan Mohapatra, Prashant B Musmade, Uday Venkat Mateti and Saleemulla Khan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The International Journal of Health Planning and Management and Strain.

In The Last Decade

D Sreedhar

34 papers receiving 160 citations

Peers

D Sreedhar

PPCH

PHEOH

CAM

Virendra S Ligade India

А. Stoimenova Bulgaria

Shahnaz Ali United Kingdom

Barbara Sauer Germany

Rachmat Hidayat Indonesia

Siukan Law Hong Kong

Srinivas Hebbar India

Abdulgafar Olayiwola Jimoh Nigeria

Upendra C. Galgatte India

Lingli Zhang China

Virendra S Ligade India

D Sreedhar

40 ×1.2

12 ×0.5

PPCH

18 ×0.8

PHEOH

10 ×0.6

CAM

16 ×1.0

Citations per year, relative to D Sreedhar D Sreedhar (= 1×) peers Virendra S Ligade

Countries citing papers authored by D Sreedhar

Since Specialization

Citations

This map shows the geographic impact of D Sreedhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Sreedhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Sreedhar more than expected).

Fields of papers citing papers by D Sreedhar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Sreedhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Sreedhar. The network helps show where D Sreedhar may publish in the future.

Co-authorship network of co-authors of D Sreedhar

This figure shows the co-authorship network connecting the top 25 collaborators of D Sreedhar. A scholar is included among the top collaborators of D Sreedhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Sreedhar. D Sreedhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sreedhar, D, et al.. (2024). Pollution Sensitivity and Resistance Assessment of Native Ornamental Plants for Landscaping in Various Factories. SHILAP Revista de lepidopterología. 15(Nov, 11). 1–13. 1 indexed citations

Musmade, Prashant B, et al.. (2024). A deep dive into the development of complex generics: A comprehensive review. Journal of Applied Pharmaceutical Science. 2 indexed citations

Sreedhar, D, et al.. (2024). Economic assessment of hemodialysis patients in tertiary and charitable hospitals: A prospective multicenter study in India. Journal of Applied Pharmaceutical Science.

Sreedhar, D, et al.. (2023). Enrolment, utilisation, and best practices followed by hemodialysis patients concerning government and private health insurance schemes in tertiary care hospital. Clinical Epidemiology and Global Health. 24. 101412–101412. 3 indexed citations

Sreedhar, D, et al.. (2023). Cost-Minimization Analysis of Medications Used in the Management of End-stage Renal Disease. Indian Journal of Pharmaceutical Education and Research. 57(1s). s140–s147. 1 indexed citations

Prabhu, Smitha, et al.. (2023). Awareness level regarding adverse reactions caused by cosmetic products among Indian women: A cross-sectional study. Journal of Cutaneous and Aesthetic Surgery. Publish Ahead of Print(2). 101–107. 1 indexed citations

Sreedhar, D, et al.. (2022). Dermatological research in India: A brief bibliometric analysis of publications during 1999–2019. Journal of Cutaneous and Aesthetic Surgery. 15(1). 77–77.

Sreedhar, D, et al.. (2022). The rise of E-pharmacy in India. Indian Journal of Pharmacology. 54(4). 282–291. 12 indexed citations

Sreedhar, D, et al.. (2022). Traceability of counterfeit drugs in pharma supply chain through Blockchain Technology - A Systematic Review of the Evidence. Research Journal of Pharmacy and Technology. 908–912. 3 indexed citations

10.

Sreedhar, D, et al.. (2022). Does India need a new pharmaceutical policy? Examining the implications of the drug price control order. The International Journal of Health Planning and Management. 37(6). 3028–3038.

11.

Shetty, Ankitha, et al.. (2021). Pharma Insurance: A Mechanism for Risk Mitigation. Research Journal of Pharmacy and Technology. 2659–2664.

12.

Sreedhar, D, et al.. (2020). Ban of Cosmetic Testing on Animals: A Brief Overview. International Journal of Current Research and Review. 12(14). 113–116. 36 indexed citations

13.

Udupa, N, et al.. (2018). Knowledge and attitude of Ayurvedic Physicians towards Adverse drug reactions and reporting methods in Udupi region. Research Journal of Pharmacy and Technology. 11(1). 117–117. 5 indexed citations

14.

Sreedhar, D, et al.. (2015). A survey on doctor’s expectation from medical representative in Karnataka state. International Journal of Current Research and Review. 7(8). 75–82. 2 indexed citations

15.

Ligade, Virendra S, et al.. (2014). Regulatory Scenario of Pharmaceutical Marketing Practices in India.

16.

Sreedhar, D, Manthan D Janodia, & Virendra S Ligade. (2011). Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern. Journal of Young Pharmacists. 3(4). 343–344.

17.

Janodia, Manthan D, et al.. (2011). Patents, Health Policy and Access to Medicines. Indo Global Journal of Pharmaceutical Sciences. 1(1). 33–38. 1 indexed citations

18.

Sreedhar, D, et al.. (2010). Combinational products: A regulatory review. 5(1). 52–60. 2 indexed citations

19.

Ligade, Virendra S, et al.. (2009). Cosmeceuticals: Are they truly worth the cost?. Indian Journal of Dermatology Venereology and Leprology. 75(1). 8–8. 4 indexed citations

20.

Ramesh, K. & D Sreedhar. (1998). Optically enhanced tiling (OET) in digital fringe pattern analysis. Strain. 34(4). 127–130. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact